APOA-I: A Possible Novel Biomarker for Metabolic Side Effects in First Episode Schizophrenia

The purpose of this study was to investigate the change in plasma protein expression in first episode schizophrenia after an 8-week treatment with risperidone, and to explore potential biomarkers for metabolic side effects associated with risperidone treatment. Eighty first-episode schizophrenia pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xueqin, Li, Xue, Gao, Jinsong, Zhao, Jingping, Li, Youhui, Fan, Xiaoduo, Lv, Luxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978061/
https://www.ncbi.nlm.nih.gov/pubmed/24710015
http://dx.doi.org/10.1371/journal.pone.0093902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978061/
https://www.ncbi.nlm.nih.gov/pubmed/24710015
http://dx.doi.org/10.1371/journal.pone.0093902

Ejemplares similares